GlobalData on MSN3d
MHLW accepts GSK’s multiple myeloma treatment NDA for review
The NDA includes a combination of Blenrep with bortezomib plus dexamethasone (BorDex) or pomalidomide plus dexamethasone ...
Kingfisher lifts lower end of guidance, GSK's Blenrep accepted for review in Japan
London open The FTSE 100 is expected to open 54 points higher on Tuesday, having closed up 0.07% on Monday at 8,278.44.
STAT1d
First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
Ace investor Ashish Kacholia dumped these 5 stocks. Here’s all you need to know.
Kacholia turned heads when he exited these stocks between December 2023 and June 2024. Was it a mistake or will his decision ...
Moderna: Cutting Costs At Just The Worst Time
Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...
The greatest British shares to invest in: Their steady and dependable growth is a testament to the power of UK plc
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
Rates to plunge to 2.75pc next year, says HSBC
However, the analysts said: “Given our own forecast that CPI inflation will rise back to 2.9pc by January next year (perhaps ...
Pharmabiz2d
Neuberg Diagnostics launches personalized genomics platform, “Geniee-Decode your DNA”
Neuberg Diagnostics, a global leader in cutting-edge healthcare diagnostics, has officially launched its groundbreaking personalized genomics platform, “Geniee-Decode your DNA”. The launch signifies a ...
GlobalData on MSN5d
Disease modifiers may take over PAH landscape, says Cereno CEO
As more drugs approach late-stage development for PAH, Cereno Scientific’s CEO expects more successful disease-modifying ...